Dawnrays Pharmaceutical (Holdings) Limited

SEHK:2348 Stock Report

Mkt Cap: HK$2.0b

Dawnrays Pharmaceutical (Holdings) Financial Health

How is Dawnrays Pharmaceutical (Holdings)'s financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 2348's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥543.3M).

Long Term Liabilities: 2348's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥250.9M).


Debt to Equity History and Analysis

Debt Level: 2348 has more cash than its total debt.

Reducing Debt: 2348's debt to equity ratio has increased from 0% to 1% over the past 5 years.

Debt Coverage: 2348's debt is well covered by operating cash flow (2096.3%).

Interest Coverage: 2348 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies